Results 181 to 190 of about 11,689 (208)
Some of the next articles are maybe not open access.
Reactogenicity and immunogenicity of inactivated hepatitis A vaccines
Vaccine, 1992Two inactivated hepatitis A virus (HAV) candidate vaccine strain were tested, derived from strains CLF and HM175. Neither vaccine increased liver enzymes levels and reactogenicity was similar to that observed with other alum-absorbed products. Antibody responses were dose-dependent and protection against HAV can be presumed to last for at least three ...
Just M, Berger R
openaire +3 more sources
Immunogenicity and reactogenicity of new multivalent pneumococcal vaccines
Zentralblatt für Bakteriologie, Mikrobiologie und Hygiene. 1. Abt. Originale. A, Medizinische Mikrobiologie, Infektionskrankheiten und Parasitologie, 1982In a study conducted in two phases at one month's interval, 22 healthy adult volunteers received a tetravalent (1, 3, 4, 12F) polysaccharide pneumococcal vaccine; 21 other subjects received another tetravalent (14, 18C, 19F, 23F) vaccine and 25 received a pentadecavalent vaccine (1, 3, 4, 6A, 7F, 8, 9N, 11A, 12F, 14, 15F, 18C, 19F, 23F).
G, Wiedermann +4 more
openaire +2 more sources
REACTOGENICITY TRENDS BY AGE TO INFLUENZA AND PNEUMOCOCCAL VACCINES
Journal of the American Geriatrics Society, 2005Authors replicate about an experience of vaccination that involved 320 individuals aged 65 and older attending one hospital geriatric unit, with the results of a study performed on 29,086 persons aged 65 and older (mean age 74.6, range 65–102) during the fall of 1999 in association with the Sicilian Region Public Health Authorities.
D'Alessandro, Daniela +3 more
openaire +2 more sources
Reactogenicity, the occurrence of vaccine side effects, can impact vaccine acceptance. There is limited data comparing the reactogenicity of COVID-19 vaccines to other routinely used vaccines, such as the meningococcal conjugate vaccine (MenACWY).
Anthony M Marchese +2 more
exaly +2 more sources
Reactogenicity and immunogenicity of a double-strength acellular pertussis vaccine
Vaccine, 1992The reactogenicity and immunogenicity of a double-strength acellular pertussis vaccine were evaluated after administration to 16 4-6-year-old children. The vaccine contained toxoided lymphocytosis-promoting factor (6.0 micrograms/dose), filamentous haemagglutinin (70 micrograms/dose), agglutinogens (1.4 micrograms/dose) and the 69 kDa protein ...
D A, Blumberg +9 more
openaire +2 more sources
Diphtheria-Pertussis-Tetanus Vaccine: Reactogenicity of Commercial Products
Pediatrics, 1979Parents from four practices were surveyed to ascertain reactions of children to diphtheria-pertussis-tetanus (DPT) vaccine in the 48 hours after immunization. Vaccines were administered according to current recommendations. Responses were scored in three categories: temperature, behavioral changes, and local reactions. Questionnaires were returned by 1,
R M, Barkin, M E, Pichichero
openaire +2 more sources
Reactogenicity and Antigenicity of the Rhesus Rotavirus Vaccine in Venezuelan Children
Journal of Infectious Diseases, 1987Les rotavirus responsables de nombreux cas de diarrhees chez l'enfant contribuent a la forte mortalite infantile dans les pays en developpement.
I, Perez-Schael +8 more
openaire +2 more sources
Reactogenicity and immunogenicity of three different lots of a hepatitis A vaccine
Vaccine, 1992To study the immunogenicity and reactogenicity of an inactivated hepatitis A vaccine, 204 healthy individuals were randomized into three equal groups, each to receive a different vaccine lot. Each subject received a total of three doses, each of 720 ELISA units of hepatitis A vaccine HM175, according to a 0 and 1 month primary vaccination schedule ...
L. Theilmann +12 more
openaire +2 more sources
The relationship between the immunogenicity and reactogenicity of vaccines: A narrative review
VaccineThe relationship between vaccine reactogenicity and immunogenicity remains an underexplored but increasingly critical area of vaccinology. This narrative review synthesizes evidence examining this relationship across a diverse array of vaccine platforms and pathogens.
Daniel J. Gromer +3 more
openaire +2 more sources
Reactogenicity and safety of meningococcal A and C vaccine in Saudi children
Annals of Tropical Paediatrics, 1994During an outbreak caused by group A Neisseria meningitidis in March 1992, groups A and C meningococcal polysaccharide vaccine was administered to 1,168 children aged from 2 to 18 years. Parents were surveyed to ascertain reactions of children to the vaccine and development of invasive group A meningococcal disease after immunization.
openaire +2 more sources

